노보큐어 리미티드
DE ˙ DB ˙ JE00BYSS4X48
€15.18 ↑1.51 (11.05%)
2026-06-05
주가
SecurityDE:038 / NovoCure Limited
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership1,551,554 shares
Latest Disclosed Value $ 16,911,939
Renaissance Technologies Llc reports 11.80% increase in ownership of 038 / NovoCure Limited

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 1,551,554 shares of NovoCure Limited (DE:038) valued at $13,669,191 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,387,754 shares of NovoCure Limited. This represents a change in shares of 11.80% during the quarter. The current value of the position is $23,544,832 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVOCURE ORD SHS G6674U108 1,551,554 163,800 11.80 16,912 -5.75 0.0265
2026-02-12 2025-12-31 13F NOVOCURE ORD SHS G6674U108 1,387,754 314,900 29.35 17,944 29.45 0.0278
2025-11-13 2025-09-30 13F NOVOCURE ORD SHS G6674U108 1,072,854 -227,200 -17.48 13,861 -40.10 0.0183
2025-08-13 2025-06-30 13F NOVOCURE ORD SHS G6674U108 1,300,054 531,400 69.13 23,141 68.94 0.0308
2025-05-14 2025-03-31 13F NOVOCURE ORD SHS G6674U108 768,654 34,300 4.67 13,697 -37.41 0.0207
2025-02-13 2024-12-31 13F NOVOCURE ORD SHS G6674U108 734,354 -9,800 -1.32 21,884 88.14 0.0324
2024-11-13 2024-09-30 13F NOVOCURE ORD SHS G6674U108 744,154 -16,021 -2.11 11,631 -10.68 0.0175
2024-08-09 2024-06-30 13F NOVOCURE ORD SHS G6674U108 760,175 480,600 171.90 13,022 325,425.00 0.0221
2024-05-13 2024-03-31 13F NOVOCURE ORD SHS G6674U108 279,575 178,200 175.78 4 300.00 0.0069
2024-02-13 2023-12-31 13F NOVOCURE ORD SHS G6674U108 101,375 101,375 2 0.0023
2022-11-14 2022-09-30 13F NOVOCURE ORD SHS G6674U108 0 -18,386 -100.00 0 -100.00
2022-08-12 2022-06-30 13F NOVOCURE ORD SHS G6674U108 18,386 -29,589 -61.68 1,278 -67.85 0.0015
2022-05-13 2022-03-31 13F NOVOCURE ORD SHS G6674U108 47,975 -131,116 -73.21 3,975 -70.44 0.0047
2022-02-11 2021-12-31 13F NOVOCURE ORD SHS G6674U108 179,091 -34,884 -16.30 13,446 -45.91 0.0167
2021-11-12 2021-09-30 13F NOVOCURE ORD SHS G6674U108 213,975 -12,800 -5.64 24,857 -50.59 0.0321
2021-08-13 2021-06-30 13F NOVOCURE ORD SHS G6674U108 226,775 -181,800 -44.50 50,303 -6.85 0.0628
2021-05-13 2021-03-31 13F NOVOCURE ORD SHS G6674U108 408,575 110,605 37.12 54,005 4.74 0.0672
2021-02-10 2020-12-31 13F NOVOCURE ORD SHS G6674U108 297,970 -679,700 -69.52 51,561 -52.62 0.0560
2020-11-13 2020-09-30 13F NOVOCURE ORD SHS G6674U108 977,670 -1,022,900 -51.13 108,824 -8.27 0.1087
2020-08-13 2020-06-30 13F NOVOCURE ORD SHS G6674U108 2,000,570 -244,900 -10.91 118,634 -21.54 0.1024
2020-05-14 2020-03-31 13F NOVOCURE ORD SHS G6674U108 2,245,470 3,475 0.15 151,210 -19.97 0.1469
2020-02-13 2019-12-31 13F NOVOCURE ORD SHS G6674U108 2,241,995 -133,775 -5.63 188,933 6.35 0.1452
2019-11-13 2019-09-30 13F NOVOCURE ORD SHS G6674U108 2,375,770 320,300 15.58 177,660 36.70 0.1504
2019-08-12 2019-06-30 13F NOVOCURE ORD SHS G6674U108 2,055,470 199,200 10.73 129,967 45.35 0.1144
2019-05-14 2019-03-31 13F NOVOCURE ORD SHS G6674U108 1,856,270 785,800 73.41 89,417 149.50 0.0813
2019-02-12 2018-12-31 13F NOVOCURE ORD SHS G6674U108 1,070,470 231,275 27.56 35,839 -18.50 0.0392
2018-11-13 2018-09-30 13F NOVOCURE ORD SHS G6674U108 839,195 156,592 22.94 43,974 105.82 0.0452
2018-08-13 2018-06-30 13F/A-1 NOVOCURE ORD SHS G6674U108 682,603 501,203 276.30 21,365 440.20 0.0233
2018-08-13 2018-06-30 13F NOVOCURE ORD SHS G6674U108 181,400 3,955
2018-05-14 2018-03-31 13F NOVOCURE ORD SHS G6674U108 181,400 -74,875 -29.22 3,955 -23.60 0.0043
2018-02-13 2017-12-31 13F NOVOCURE ORD SHS G6674U108 256,275 256,275 5,177 0.0057
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.